‘Twist Bioscience Corporation to Present at J.P. Morgan Healthcare Conference\n\nOn Monday, January 8, 2024, Twist Bioscience Corporation (NASDAQ:TWST) CEO and co-founder, Emily M. Leproust, Ph.D., will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA. The presentation will be webcast live and can be accessed on the company’s website. A replay of the presentation will be available for 30 days after the event.\n\nTwist Bioscience is a leading synthetic biology and genomics company that has developed a disruptive DNA synthesis platform. The company’s technology allows for the industrialization of engineering biology by “writing” DNA on a silicon chip. This technology has a wide range of applications, including synthetic genes, tools for next-generation sequencing, and antibody libraries for drug discovery and development.\n\nIn addition to its current products, Twist Bioscience is also exploring opportunities in digital data storage in DNA and biologics drug discovery. The company’s products are used in various industries, including healthcare, industrial chemicals, agriculture, and academic research.\n\nTwist Bioscience recently announced strong financial results for the fiscal fourth quarter and full-year fiscal 2023. This may have contributed to the company’s stock price rally, with shares ending the last trading session 12.5% higher.\n\nThe company is expected to report a quarterly loss of $0.80 per share, representing a year-over-year change of -8.1%. Revenues are expected to be $67.33 million, up 24.1% from the same quarter last year. The consensus EPS estimate for the quarter has been revised 12.7% higher over the last 30 days, which could lead to price appreciation.\n\nTwist Bioscience is part of the Zacks Medical

Three High-Risk Stocks with Potential for Big Gains in 2024\n\nAfter a year of market volatility and uncertainty, now may be the perfect time for investors to take a calculated risk and invest in high-risk, high-reward stocks. While these stocks come with inherent risks, they also offer the potential for significant gains if things go right. \n\nLuminar Technologies (NASDAQ:LAZR) is a lidar technology company that specializes in autonomous vehicles. A rough year for the EV sector, Luminar's long-term growth story remains compelling. With superior lidar technology and major partnerships with top automakers, Luminar is well-positioned to capitalize on the growing demand for advanced driver assistance systems. While near-term headwinds may persist, Luminar's current valuation presents a compelling opportunity for investors.\n\nTerran Orbital Corporation (NYSE:LLAP) is a small satellite manufacturer that has faced turbulence since going public. The company's multi-billion dollar backlog and growing pipeline of opportunities suggest a bright future. With a recent deal for Lockheed's Space Development Agency project and a backlog of over $2.6 billion, Terran Orbital is well-positioned for long-term growth. \n\nHive Blockchain Technologies (NASDAQ:HIVE) is a cryptocurrency miner that has been under pressure in recent months. I believe the company's long-term growth story remains intact. Hive mines Ethereum, Ethereum Classic, and Bitcoin. The company's operations are powered by green energy, which is a major differentiator in the crypto mining space. Additionally, Hive has been expanding its operations aggressively. It recently acquired a massive data center in Canada, which will increase its mining capacity by 50%. The company also has plans to expand into the United States and Europe. The recent pullback in crypto prices, I believe Hive is well-positioned for long-term success. As the market for cryptocurrencies continues to grow, so will the demand for mining operations. And with its focus on sustainability, Hive could attract environmentally-conscious investors. In addition, the company's expansion plans could lead to increased revenue and profitability in the future. \n\n While these stocks come with inherent risks, they also offer the potential for significant gains in the future.